All tumors (n= 422) | ER-positive (n= 270) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariatea | Univariate | Multivariatea | |||||||||
HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
HMG-CoAR (0 vs. 1 to 2+) | 0.68 | 0.51 to 0.90 | 0.009 | 0.67 | 0.49 to 0.91 | 0.01 | 0.66 | 0.46 to 0.95 | 0.024 | 0.65 | 0.45 to 0.96 | 0.029 |
Grade (I and II vs. III) | 1.88 | 1.46 to 2.42 | <0.001 | 1.58 | 1.11 to 2.25 | 0.012 | 1.85 | 1.32 to 2.60 | <0.001 | 1.56 | 1.04 to 2.34 | 0.03 |
Age (continuous) | 0.95 | 0.95 to 0.99 | 0.002 | 0.97 | 0.95 to 1.01 | 0.071 | 0.95 | 0.93 to 0.98 | 0.001 | 0.95 | 0.92 to 0.99 | 0.015 |
Nodal status (negative vs. positive) | 1.7 | 1.26 to 2.29 | 0.001 | 2.12 | 1.47 to 3.28 | <0.001 | 1.42 | 0.94 to 2.15 | 0.098 | 1.56 | 0.95 to 2.57 | 0.079 |
Tumor size (continuous) | 1.16 | 0.90 to 1.50 | 0.254 | 1.27 | 0.91 to 1.77 | 0.159 | 1.17 | 0.84 to 1.64 | 0.361 | 1.22 | 0.81 to 1.84 | 0.352 |
ER status (0 to 10% vs. 11 to 100%) | 0.71 | 0.54 to 0.94 | 0.018 | 0.65 | 0.37 to 1.13 | 0.126 | ||||||
PR status (0 to 10% vs. 11 to 100%) | 0.73 | 0.54 to 0.97 | 0.031 | 1.37 | 0.77 to 2.43 | 0.285 | 0.94 | 0.832 to 1.19 | 0.95 | 2.28 | 0.72 to 7.27 | 0.163 |
Treatment (tamoxifen vs. control) | 0.78 | 0.60 to 0.98 | 0.033 | 0.68 | 0.50 to 0.92 | 0.011 | 0.61 | 0.44 to 0.86 | 0.005 | 0.58 | 0.39 to 0.84 | 0.005 |